Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6153213 | 0.86 | CA1 (0.32) | MEN1KMT2A | |
| SCHEMBL13497137 | 0.79 | MEN1 (0.35) | MEN1KMT2AALDH1A1HPGD | |
| SCHEMBL25472230 | 0.77 | — | — | |
| SCHEMBL12000699 | 0.74 | — | — | |
| SCHEMBL22078932 | 0.73 | CA1 (0.32) | KMT2A | |
| SCHEMBL22130744 | 0.73 | CA1 (0.32) | KMT2A | |
| SCHEMBL14016360 | 0.73 | CA1 (0.32) | KMT2A | |
| SCHEMBL4476803 | 0.73 | — | — | |
| SCHEMBL13631561 | 0.73 | — | — | |
| SCHEMBL9409590 | 0.71 | CA1 (0.34) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753360-B2 | Circular economy methods of preparing unsaturated compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2023-09-12 | — | — | US | disclosed |
| US-20200115400-A1 | METHOD FOR PRODUCING SILICON COMPOUND, AND SILICON COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-04-16 | — | — | US | disclosed |
| US-10435345-B2 | Circular economy methods of preparing unsaturated compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2019-10-08 | — | — | US | disclosed |
| US-20170362155-A1 | CIRCULAR ECONOMY METHODS OF PREPARING UNSATURATED COMPOUNDS | INTERNATIONAL FLAVORS AND FRAGRANCES INC. | 2017-12-21 | — | — | US | disclosed |
| US-20170362155-A1 | CIRCULAR ECONOMY METHODS OF PREPARING UNSATURATED COMPOUNDS | INTERNATIONAL FLAVORS AND FRAGRANCES INC. | 2017-12-21 | — | — | US | disclosed |
| EP-3257831-A2 | CIRCULAR ECONOMY METHODS OF PREPARING UNSATURATED COMPOUNDS | International Flavors & Fragrances Inc. (US) | 2017-12-20 | — | — | EP | disclosed |
| US-20150010855-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE COMPOSITION, AND RESIST FILM, RESIST-COATED MASK BLANKS, RESIST PATTERN FORMING METHOD AND PHOTOMASK EACH USING THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2015-01-08 | — | — | US | disclosed |
| US-20130136900-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM, PATTERN FORMING METHOD, ELECTRONIC DEVICE MANUFACTURING METHOD, AND ELECTRONIC DEVICE, EACH USING THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2013-05-30 | — | — | US | disclosed |
| US-8021822-B2 | Positive resist compositions and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2011-09-20 | — | — | US | disclosed |
| US-8021822-B2 | Positive resist compositions and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2011-09-20 | — | — | US | disclosed |
| EP-1000924-A1 | ACID-SENSITIVE COMPOUND AND RESIN COMPOSITION FOR PHOTORESIST | Daichel Chemical Industries Ltd (JP) | 2000-05-17 | — | — | EP | disclosed |
| EP-0373915-B1 | NOVEL THROMBOXANE A2 ANTAGONISTS | BTG INTERNATIONAL LIMITED (GB) | 1993-08-18 | — | — | EP | disclosed |
| US-5106870-A | Antiinflammatory agents, antianaphylactic agents | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1992-04-21 | — | — | US | disclosed |
| US-5055582-A | Process for preparing thromboxane A2 antagonists | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1991-10-08 | — | — | US | disclosed |
| US-4992563-A | Benzopyran intermediates for use in manufacturing thromboxane A2 antagonists | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1991-02-12 | — | — | US | disclosed |
| US-4992581-A | From perhydroketo-4,7-methanoindene | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1991-02-12 | — | — | US | disclosed |
| US-4973604-A | Thromboxane A2 antagonists and pharmaceutical compositions thereof | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1990-11-27 | — | — | US | disclosed |
| US-4942256-A | 7-(3-ALPHA-(1-(((PHENYLAMINO)-THIOXOMETHYL)HYDRAZINO)ETHYL)-BI CYCLO(2.2.1)HEPTENOIC ACIDS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1990-07-17 | — | — | US | disclosed |
| WO-1990006917-A1 | NOVEL THROMBOXANE A2 ANTAGONISTS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1990-06-28 | — | — | WO | disclosed |
| EP-0373915-A1 | Novel thromboxane A2 antagonists | BTG INTERNATIONAL LIMITED (GB) | 1990-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362155-A1 | CIRCULAR ECONOMY METHODS OF PREPARING UNSATURATED COMPOUNDS | FADS1, SCD, FASN | MEN1 3793/4885KMT2A 2859/4885ALDH1A1 790/4885 |
| US-10435345-B2 | Circular economy methods of preparing unsaturated compounds | FADS1, SCD, FASN | MEN1 3793/4885KMT2A 2859/4885ALDH1A1 790/4885 |
| US-20200115400-A1 | METHOD FOR PRODUCING SILICON COMPOUND, AND SILICON COMPOUND | SI, SIK1, CA1 | MEN1 454/4885KMT2A 2051/4885ALDH1A1 881/4885 |
| US-11753360-B2 | Circular economy methods of preparing unsaturated compounds | FADS1, SCD, FASN | MEN1 3793/4885KMT2A 2859/4885ALDH1A1 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.